STABLE-SR (Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm) for the Treatment of Nonparoxysmal Atrial Fibrillation: A Prospective, Multicenter Randomized Clinical Trial [Original Articles]

Conclusions:
STABLE-SR is a simplified, personalized, and effective ablation strategy in nonparoxysmal AF patients. More importantly, over 50% nonparoxysmal AF patients do not need further ablation beyond CPVI and therefore can avoid excessive ablation.

Clinical Trial Registration:
URL: http://www.clinicaltrials.gov. Unique identifier: NCT01761188.

Source: Circulation: Arrhythmia and Electrophysiology - November 15, 2017 Category: Cardiology Authors: Yang, B., Jiang, C., Lin, Y., Yang, G., Chu, H., Cai, H., Lu, F., Zhan, X., Xu, J., Wang, X., Ching, C.-K., Singh, B., Kim, Y.-H., Chen, M., for the STABLE-SR Investigators* Tags: Arrhythmias, Atrial Fibrillation Original Articles Source Type: research